Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Intensive Care Medicine
Published in: Intensive Care Medicine 9/2016

01-09-2016 | Original

The feasibility and safety of extracorporeal carbon dioxide removal to avoid intubation in patients with COPD unresponsive to noninvasive ventilation for acute hypercapnic respiratory failure (ECLAIR study): multicentre case–control study

Authors: Stephan Braune, Annekatrin Sieweke, Franz Brettner, Thomas Staudinger, Michael Joannidis, Serge Verbrugge, Daniel Frings, Axel Nierhaus, Karl Wegscheider, Stefan Kluge

Published in: Intensive Care Medicine | Issue 9/2016

Login to get access

Abstract

Introduction

The aim of the study was to evaluate the feasibility and safety of avoiding invasive mechanical ventilation (IMV) by using extracorporeal CO2 removal (ECCO2R) in patients with acute exacerbation of chronic obstructive pulmonary disease (COPD) and acute hypercapnic respiratory failure refractory to noninvasive ventilation (NIV).

Methods

Case–control study. Patients with acute hypercapnic respiratory failure refractory to NIV being treated with a pump-driven veno-venous ECCO2R system (iLA-Activve®; Novalung, Heilbronn, Germany) were prospectively observed in five European intensive care units (ICU). Inclusion criteria were respiratory acidosis (pH ≤ 7.35, PaCO2 > 45 mmHg) with predefined criteria for endotracheal intubation (ClinicalTrials.gov NCT01784367). The historical controls were patients with acute hypercapnic respiratory failure refractory to NIV who were treated with IMV. The matching criteria were main diagnosis, age, SAPS-II score and pH.

Results

Twenty-five cases (48.0 % male, mean age 67.3 years) were matched with 25 controls. Intubation was avoided in 14 patients (56.0 %) in the ECCO2R group with a mean extracorporeal blood flow of 1.3 L/min. Seven patients were intubated because of progressive hypoxaemia and four owing to ventilatory failure despite ECCO2R and NIV. Relevant ECCO2R-associated adverse events were observed in 11 patients (44.0 %), of whom 9 (36.0 %) suffered major bleeding complications. The mean time on IMV, ICU stay and hospital stay in the case and control groups were 8.3 vs. 13.7, 28.9 vs. 24.0 and 36.9 vs. 37.0 days, respectively, and the 90-day mortality rates were 28.0 vs. 28.0 %.

Conclusions

The use of veno-venous ECCO2R to avoid invasive mechanical ventilation was successful in just over half of the cases. However, relevant ECCO2R-associated complications occurred in over one-third of cases. Despite the shorter period of IMV in the ECCO2R group there were no significant differences in length of stay or in 28- and 90-day mortality rates between the two groups. Larger, randomised studies are warranted for further assessment of the effectiveness of ECCO2R.
Appendix
Available only for authorised users
Literature
1.
2.
Chandra D, Stamm JA, Taylor B, Ramos RM, Satterwhite L, Krishnan JA et al (2012) Outcomes of noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease in the United States, 1998–2008. Am J Respir Crit Care Med 185:152–159CrossRefPubMedPubMedCentral
3.
Lindenauer PK, Stefan MS, Shieh MS, Pekow PS, Rothberg MB, Hill NS (2014) Outcomes associated with invasive and noninvasive ventilation among patients hospitalized with exacerbations of chronic obstructive pulmonary disease. JAMA Intern Med 174:1982–1993CrossRefPubMedPubMedCentral
4.
Schonhofer B (2015) Noninvasive ventilation in patients with persistent hypercapnia. Med Klin Intensivmed Notfmed 110:182–187CrossRefPubMed
5.
Brochard L, Mancebo J, Wysocki M, Lofaso F, Conti G, Rauss A et al (1995) Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 333:817–822CrossRefPubMed
6.
Squadrone E, Frigerio P, Fogliati C, Gregoretti C, Conti G, Antonelli M et al (2004) Noninvasive vs invasive ventilation in COPD patients with severe acute respiratory failure deemed to require ventilatory assistance. Intensive Care Med 30:1303–1310CrossRefPubMed
7.
Confalonieri M, Garuti G, Cattaruzza MS, Osborn JF, Antonelli M, Conti G et al (2005) A chart of failure risk for noninvasive ventilation in patients with COPD exacerbation. Eur Respir J 25:348–355CrossRef
8.
Quinnell TG, Pilsworth S, Shneerson JM, Smith IE (2006) Prolonged invasive ventilation following acute ventilatory failure in COPD: weaning results, survival, and the role of noninvasive ventilation. Chest 129:133–139CrossRefPubMed
9.
Conti G, Antonelli M, Navalesi P, Rocco M, Bufi M, Spadetta G et al (2002) Noninvasive vs. conventional mechanical ventilation in patients with chronic obstructive pulmonary disease after failure of medical treatment in the ward: a randomized trial. Intensive Care Med 28:1701–1707CrossRefPubMed
10.
Schonhofer B, Euteneuer S, Nava S, Suchi S, Kohler D (2002) Survival of mechanically ventilated patients admitted to a specialised weaning centre. Intensive Care Med 28:908–916CrossRefPubMed
11.
Hajizadeh N, Goldfeld K, Crothers K (2015) What happens to patients with COPD with long-term oxygen treatment who receive mechanical ventilation for COPD exacerbation? A 1-year retrospective follow-up study. Thorax 70:294–296CrossRefPubMed
12.
Stefan MS, Nathanson BH, Higgins TL, Steingrub JS, Lagu T, Rothberg MB et al (2015) Comparative effectiveness of noninvasive and invasive ventilation in critically ill patients with acute exacerbation of chronic obstructive pulmonary disease. Crit Care Med 43:1386–1394CrossRefPubMedPubMedCentral
13.
Tremblay LN, Slutsky AS (2006) Ventilator-induced lung injury: from the bench to the bedside. Intensive Care Med 32:24–33CrossRefPubMed
14.
Melsen WG, Rovers MM, Bonten MJ (2009) Ventilator-associated pneumonia and mortality: a systematic review of observational studies. Crit Care Med 37:2709–2718CrossRefPubMed
15.
Jackson DL, Proudfoot CW, Cann KF, Walsh T (2010) A systematic review of the impact of sedation practice in the ICU on resource use, costs and patient safety. Crit Care 14:R59CrossRefPubMedPubMedCentral
16.
Jaber S, Jung B, Matecki S, Petrof BJ (2011) Clinical review: ventilator-induced diaphragmatic dysfunction-human studies confirm animal model findings! Crit Care 15:206CrossRefPubMedPubMedCentral
17.
Ward NS, Dushay KM (2008) Clinical concise review: mechanical ventilation of patients with chronic obstructive pulmonary disease. Crit Care Med 36:1614–1619CrossRefPubMed
18.
Braune SA, Kluge S (2013) Extracorporeal lung support in patients with chronic obstructive pulmonary disease. Minerva Anestesiol 79:934–943PubMed
19.
Crotti S, Lissoni A, Tubiolo D, Azzari S, Tarsia P, Caspani L et al (2012) Artificial lung as an alternative to mechanical ventilation in COPD exacerbation. Eur Respir J 39:212–215CrossRefPubMed
20.
Burki NK, Mani RK, Herth FJ, Schmidt W, Teschler H, Bonin F et al (2013) A novel extracorporeal CO2 removal system: results of a pilot study of hypercapnic respiratory failure in patients with COPD. Chest 143:678–686CrossRefPubMed
21.
Kluge S, Braune SA, Engel M, Nierhaus A, Frings D, Ebelt H et al (2012) Avoiding invasive mechanical ventilation by extracorporeal carbon dioxide removal in patients failing noninvasive ventilation. Intensive Care Med 38:1632–1639CrossRefPubMed
22.
Del Sorbo L, Pisani L, Filippini C, Fanelli V, Fasano L, Terragni P et al (2015) Extracorporeal CO2 removal in hypercapnic patients at risk of noninvasive ventilation failure: a matched cohort study with historical control. Crit Care Med 43:120–127CrossRefPubMed
23.
Hermann A, Riss K, Schellongowski P, Bojic A, Wohlfarth P, Robak O et al (2015) A novel pump-driven veno-venous gas exchange system during extracorporeal CO2-removal. Intensive Care Med 41:1773–1780CrossRefPubMed
24.
Hermann A, Staudinger T, Bojic A, Riss K, Wohlfarth P, Robak O et al (2014) First experience with a new miniaturized pump-driven venovenous extracorporeal CO2 removal system (iLA Activve): a retrospective data analysis. ASAIO J 60:342–347CrossRef
25.
Schulman S, Kearon C (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 3:692–694CrossRefPubMed
26.
Pisani L, Fasano L, Corcione N, Comellini V, Guerrieri A, Ranieri MV et al (2015) Effects of extracorporeal CO2 removal on inspiratory effort and respiratory pattern in patients who fail weaning from mechanical ventilation. Am J Respir Crit Care Med 192:1392–1394CrossRefPubMed
27.
Mani RK, Schmidt W, Lund LW, Herth FJ (2013) Respiratory dialysis for avoidance of intubation in acute exacerbation of COPD. ASAIO J 59:675–678CrossRefPubMed
28.
Spinelli E, Crotti S, Zachetti L, Bottino N, Berto V, Russo R et al (2013) Effect of extracorporeal CO2 removal on respiratory rate in spontaneously breathing patients with chronic obstructive pulmonary disease exacerbation. Crit Care 17(Suppl 2):P128CrossRefPubMedCentral
29.
Sklar MC, Beloncle F, Katsios CM, Brochard L, Friedrich JO (2015) Extracorporeal carbon dioxide removal in patients with chronic obstructive pulmonary disease: a systematic review. Intensive Care Med 41:1752–1762CrossRefPubMed
30.
Karagiannidis C, Kampe KA, Sipmann FS, Larsson A, Hedenstierna G, Windisch W et al (2014) Veno-venous extracorporeal CO2 removal for the treatment of severe respiratory acidosis: pathophysiological and technical considerations. Crit Care 18:R124CrossRefPubMedPubMedCentral
31.
32.
Gorlinger K, Bergmann L, Dirkmann D (2012) Coagulation management in patients undergoing mechanical circulatory support. Best Pract Res Clin Anaesthesiol 26:179–198CrossRefPubMed
33.
Kalbhenn J, Wittau N, Schmutz A, Zieger B, Schmidt R (2015) Identification of acquired coagulation disorders and effects of target-controlled coagulation factor substitution on the incidence and severity of spontaneous intracranial bleeding during veno-venous ECMO therapy. Perfusion 30:675–682CrossRefPubMed
34.
John S, Willam C (2015) Lung and kidney failure: pathogenesis, interactions, and therapy. Med Klin Intensivmed Notfmed 110:452–458CrossRefPubMed
35.
Forster C, Schriewer J, John S, Eckardt KU, Willam C (2013) Low-flow CO2 removal integrated into a renal-replacement circuit can reduce acidosis and decrease vasopressor requirements. Crit Care 17:R154CrossRefPubMedPubMedCentral
36.
Lee DS, Chung CR, Jeon K, Park CM, Suh GY, Song YB et al (2015) Survival after extracorporeal cardiopulmonary resuscitation on weekends in comparison with weekdays. Ann Thorac Surg 101:133–140CrossRefPubMed
37.
Abrams DC, Brenner K, Burkart KM, Agerstrand CL, Thomashow BM, Bacchetta M et al (2013) Pilot study of extracorporeal carbon dioxide removal to facilitate extubation and ambulation in exacerbations of chronic obstructive pulmonary disease. Ann Am Thorac Soc 10:307–314CrossRefPubMed
Metadata
Title
The feasibility and safety of extracorporeal carbon dioxide removal to avoid intubation in patients with COPD unresponsive to noninvasive ventilation for acute hypercapnic respiratory failure (ECLAIR study): multicentre case–control study
Authors
Stephan Braune
Annekatrin Sieweke
Franz Brettner
Thomas Staudinger
Michael Joannidis
Serge Verbrugge
Daniel Frings
Axel Nierhaus
Karl Wegscheider
Stefan Kluge
Publication date
01-09-2016
Publisher
Springer Berlin Heidelberg
Published in
Intensive Care Medicine / Issue 9/2016
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-016-4452-y

Other articles of this Issue 9/2016

Intensive Care Medicine 9/2016 Go to the issue

Editorial

The editorial policy of Intensive Care Medicine

Original

Determinants of time to death in hospital in critically ill patients around the world

Original

Effect of atorvastatin on the incidence of acute kidney injury following valvular heart surgery: a randomized, placebo-controlled trial

What's New in Intensive Care

Glycemic control: please agree to disagree

Editorial

Statins do not prevent cardiac surgery-associated AKI: is ubiquinone the missing link?

Focus Editorial

Focus on nutrition